Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGS - Nasdaq Real Time Price USD

ICU Medical, Inc. (ICUI)

Compare
140.16
-4.12
(-2.86%)
At close: March 28 at 4:00:01 PM EDT
141.03
+0.87
+(0.62%)
After hours: March 28 at 7:50:33 PM EDT
Loading Chart for ICUI
  • Previous Close 144.28
  • Open 142.98
  • Bid 139.16 x 200
  • Ask 140.85 x 200
  • Day's Range 138.46 - 144.49
  • 52 Week Range 93.36 - 196.26
  • Volume 224,240
  • Avg. Volume 237,962
  • Market Cap (intraday) 3.437B
  • Beta (5Y Monthly) 0.74
  • PE Ratio (TTM) --
  • EPS (TTM) -4.84
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 190.00

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. It offers infusion therapy products, such as needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

www.icumed.com

15,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ICUI

View More

Performance Overview: ICUI

Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ICUI
9.67%
S&P 500 (^GSPC)
5.11%

1-Year Return

ICUI
30.60%
S&P 500 (^GSPC)
6.22%

3-Year Return

ICUI
37.19%
S&P 500 (^GSPC)
21.97%

5-Year Return

ICUI
25.32%
S&P 500 (^GSPC)
119.59%

Compare To: ICUI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ICUI

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    3.44B

  • Enterprise Value

    4.77B

  • Trailing P/E

    --

  • Forward P/E

    20.88

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.43

  • Price/Book (mrq)

    1.75

  • Enterprise Value/Revenue

    2.00

  • Enterprise Value/EBITDA

    18.34

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.94%

  • Return on Assets (ttm)

    1.42%

  • Return on Equity (ttm)

    -5.76%

  • Revenue (ttm)

    2.38B

  • Net Income Avi to Common (ttm)

    -117.69M

  • Diluted EPS (ttm)

    -4.84

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    320.81M

  • Total Debt/Equity (mrq)

    83.59%

  • Levered Free Cash Flow (ttm)

    77.01M

Research Analysis: ICUI

View More

Company Insights: ICUI

Research Reports: ICUI

View More

People Also Watch